T3	Subject 35 56	parkinsonian patients
T4	Treatment 62 71	levo-dopa
T6	Effect 80 100	diphasic dyskinesias
T7	Sub-Disorder 35 47	parkinsonian
T8	Drug 62 71	levo-dopa
T9	Treat-Disorder 166 184	abnormal movements
T10	Treatment 115 139	subcutaneous apomorphine
T11	Route 115 127	subcutaneous
T12	Drug 128 139	apomorphine
T5	Adverse_event 72 79	induced
T13	Potential_therapeutic_event 143 149	reduce
E1	Adverse_event:T5 arg:T4 arg2:T6 arg3:T3
E2	Potential_therapeutic_event:T13 arg:T10 arg2:T3
R1	has Arg1:T10 Arg2:T9
